Recent Updates
Recently added Catalysts
BMY Positive Sentiment

Bristol Myers Squibb Appoints Mayada Al-Ahmad as General Manager for Saudi Arabia & Gulf Countries Bristol Myers Squibb (BMS), a leading global biopharmaceutical company, has appointed Mayada Al-Ahmad to the position of General Manager of Saudi...

Key Takeaway: Bristol Myers Squibb has appointed Mayada Al-Ahmad as General Manager for Saudi Arabia and Gulf Countries, effective June 1, 2026. With over 24 years of experience in the pharmaceutical industry, she will lead BMS's efforts in the region, focusing on delivering innovative medicines. Her leadership is expected to align with national health priorities.
Price reaction · baseline $55.92 (2026-06-16 close) · hit after-hours · 3 other BMY headline(s) in the window, move may be shared
day 0 close · peak
-1.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Mayada Al-Ahmad brings over 24 years of leadership experience.
  • Her appointment aligns with BMS's mission to deliver transformative medicines.
  • She has a strong understanding of the Saudi and Gulf markets.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+20%
120-day peak, hindsight
Typical move
1.7%
average across 15 past catalysts
Lead asset
Muraglitazar
Phase 3 · Type 2 Diabetes

Full Press Release Details

RIYADH, Saudi Arabia , June 17, 2026 /PRNewswire/ -- Bristol Myers Squibb (BMS), a leading global biopharmaceutical company, has appointed Mayada Al-Ahmad to the position of General Manager of Saudi Arabia and Gulf Countries effective June 1, 2026. In this role, Mayada will lead the affiliate spanning Saudi Arabia, the United Arab Emirates, Kuwait, Qatar, Oman, Bahrain, and Jordan, with responsibility for advancing BMS's mission to deliver transformative medicines to patients across the region.
"As she assumes this new leadership role, Mayada's deep understanding of the Saudi and Gulf markets along with her strong regional network, position her well to lead this important affiliate into its next phase of growth. Her leadership will be instrumental in advancing our mission across the region, aligning seamlessly with national & regional health transformation priorities." said Michelle Calope, Senior Vice President | Head of Intercontinental Markets, Bristol Myers Squibb . Michelle .
"As she assumes this new leadership role, Mayada's deep understanding of the Saudi and Gulf markets along with her strong regional network, position her well to lead this important affiliate into its next phase of growth. Her leadership will be instrumental in advancing our mission across the region, aligning seamlessly with national & regional health transformation priorities." said Michelle Calope, Senior Vice President | Head of Intercontinental Markets, Bristol Myers Squibb . Michelle .
Mayada brings over 24 years of progressive leadership experience in the pharmaceutical industry, spanning commercial, strategic, and country management functions across diverse geographies, including the Middle East, Africa, Türkiye, Russia, and Intercontinental markets. She has broad therapeutic expertise in Oncology, Hematology, Cardiovascular, Neuroscience, and Diabetes; and has consistently demonstrated an ability to drive performance and cultivate strong, high-performing, patient-centric teams within varied and challenging market environments.
Commenting on her new appointment, Mayada Al-Ahmad, General Manager, Saudi Arabia & Gulf Countries, Bristol Myers Squibb , said: "I am honored and enthusiastic to step into this pivotal role, leading Bristol Myers Squibb's efforts across Saudi Arabia and the Gulf Countries. It is a privilege to contribute to our vital mission of delivering innovative medicines and making a meaningful difference in patients' lives throughout this dynamic region. I look forward to working closely with our talented team and valued partners to further our commitment to health and scientific advancement."
About Bristol Myers Squibb
Transforming Patients' Lives Through Science at Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what's possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com and follow us on LinkedIn, X, YouTube, Facebook and Instagram.

Frequently Asked Questions

Who is the new General Manager for BMS in Saudi Arabia?

Mayada Al-Ahmad has been appointed as the General Manager for Bristol Myers Squibb in Saudi Arabia and Gulf Countries.

When did Mayada Al-Ahmad start her role at BMS?

She assumed her role as General Manager effective June 1, 2026.

What experience does Mayada Al-Ahmad bring to BMS?

She brings over 24 years of leadership experience in the pharmaceutical industry.

What is the mission of Bristol Myers Squibb?

Bristol Myers Squibb aims to discover and deliver innovative medicines for serious diseases.

Last updated: Jun 17, 2026